Navigation Links
Discovery in Biological Technology

PharmatrophiX, Initially Funded by the Alzheimer's Drug Discovery Foundation, Announces Exclusive Global Collaboration with Elan

Promise of revolutionary orally-administered drugs to combat Alzheimer's began journey 8 years ago "Finding a needle in a haystack - 4 molecules out of a million" NEW YORK, Aug. 6 /PRNewswire-USNewswire/ -- New therapeutics funded by the Alzheimer's Dr...

Shanghai ChemPartner and ELARA Pharmaceuticals Expand Drug Discovery Collaboration to a New Level

SHANGHAI, Aug. 4 /PRNewswire-Asia/ -- Shanghai ChemPartner Co., Ltd., (ChemPartner) a wholly owned subsidiary of ShangPharma Corporation, announced today that it has moved its drug discovery collaboration with ELARA Pharmaceuticals to a new level. ChemPartner will provide fully integrated ser...

New method may accelerate drug discovery for difficult diseases like Parkinson's

CAMBRIDGE, Mass. (July 13, 2009) Whitehead Institute scientists have developed a rapid, inexpensive drug-screening method that could be used to target diseases that until now have stymied drug developers, such as Parkinson's disease. This technique uses baker's yeast to synthesize and screen the...

Novel drug discovery tool could identify promising new therapies for Parkinson's disease

Researchers funded by the National Institutes of Health have turned simple baker's yeast into a virtual army of medicinal chemists capable of rapidly searching for drugs to treat Parkinson's disease. In a study published online today in Nature Chemical Biology , the researchers showed that the...

Shanghai ChemPartner and Agios Expand Integrated Drug Discovery Research Collaboration

SHANGHAI, July 9 /PRNewswire-Asia/ -- Shanghai ChemPartner Co., Ltd., (ChemPartner) a wholly owned subsidiary of ShangPharma Corporation, today announces that it has expanded its integrated drug discovery research collaboration with Agios, the first biopharmaceutical company dedicated to the d...

Burnham Institute for Medical Research and Magellan BioScience Group, Inc. Announce Drug Discovery Collaboration

Magellan BioScience Group, Inc. (Magellan), a pioneer in innovative drug development from marine sources, and investigators at the Burnham Institute for Medical Research at Lake Nona (Burnham) announced today that they will begin a multidisciplinary drug discovery collaboration to identify novel ...

Monsanto, BASF Scientists Disclose Discovery of Gene Conferring Drought Tolerance in Corn Plants

Gene Provides Yield Stability During Periods of Inadequate Water Supply ST. LOUIS and LUDWIGSHAFEN, Germany, June 9, 2009 /PRNewswire-FirstCall/ -- Monsanto Company (NYSE: MON ) and BASF scientists unveiled the discovery that a naturally-occurring gene can help corn plants comb...

Genedata Launches Expressionist with Expanded Mass Spectrometry Biomarker Discovery Capabilities

Genedata Expressionist 5.2 with enhanced capabilities for Mass Spectrometry-based biomarker discovery will be demonstrated at the 57th ASMS Conference on Mass Spectrometry, May 31 - June 4, 2009, Booth# 133 at the Pennsylvania Convention Center. Philadelphia, PA (PRWEB)...

Beactica Announces Drug Discovery Agreement With Cubist Pharmaceuticals

UPPSALA, Sweden, May 25 /PRNewswire/ -- Beactica AB, the Swedish fragment-based drug discovery company, today announced that it has entered into an agreement with Cubist Pharmaceuticals, Inc. (Lexington, MA; NASDAQ: CBST ). Under the agreement, Beactica will use its Sprint(TM) surface plasmo...

Scotland Highlights New Partnerships and Cutting-Edge Drug Discovery Research

Recent stem cell advances and Sir Philip Cohen's groundbreaking research into new drug targets showcase Scotland's life sciences innovation at BIO 2009 ATLANTA, May 18 /PRNewswire/ -- At this year's BIO International Convention, May 18-21 in Atlanta, Scotland will showcase the commercial s...

Council for American Medical Innovation Brings U.S. Leaders in Medicine, Biotechnology and Discovery Together in Chicago for 'Best and Brightest Forum on Medical Innovation'

CHICAGO, April 7 /PRNewswire-USNewswire/ -- The following release is being issued by Council for American Medical Innovation: (Logo: http://www.newscom.com/cgi-bin/prnh/20090325/DC89081LOGO ) WHAT: A forum for discussion on the importance of medical science and discovery in the...

BioDuro and Roche Expand Strategic Collaboration to Provide Drug Discovery Services

BEIJING, April 6 /PRNewswire/ -- BioDuro announced today that they have entered into a strategic partnership with Roche to support discovery phase research efforts at Roche's global research sites. BioDuro will provide research services in the areas of discovery chemistry and biology, which can he...

Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development

SOUTH SAN FRANCISCO, Calif., March 24 /PRNewswire/ -- Catalyst Biosciences, Inc., a pioneer in the discovery and development of engineered proteases known as Alterase(TM) therapeutics, has appointed four new members to the company's Scientific Advisory Board (SAB). Robert J. Fletterick, Ph.D., Da...

BioDuro and AstraZeneca Expand Collaboration to Optimize Discovery Research for Respiratory and Inflammation Indications

BEIJING, March 23 /PRNewswire/ -- BioDuro and AstraZeneca announced today that they have expanded their research collaboration to optimize discovery research for Respiratory and Inflammation indications. BioDuro will provide integrated research services in the areas of discovery chemistry, d...

Frost & Sullivan European Drug Discovery Product Innovation Award Bestowed on Xenometrix AG

LONDON, March 19 /PRNewswire/ -- The 2009 Frost & Sullivan European Drug Discovery Product Innovation Award is presented to Xenometrix AG in recognition of its active role in the production of single and multiple endpoint cytotoxicity assays. (Logo: http://www.newscom.com/cgi-bin/prnh/...

Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)

CAMBRIDGE, Mass., March 18 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that four abstracts from the company's hepatitis C antiviral...

Med Discovery and Laborium Biopharma Extend Their Development Partnership to Include Mammalian Cell Culture Processes and Clinical Manufacturing for All Products in Med Discovery's Portfolio

Med Discovery SA, a specialized protein-based therapeutics oncology company, is proud to announce that they have extended their global partnership agreement with Laborium Biopharma, a subsidiary of Validapro BioSciences Inc. to encompass the cell culture process development and clinical manufactu...

Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies

MOUNTAIN VIEW, Calif., March 10 /PRNewswire/ -- Frost & Sullivan recognizes BioTrove, Inc. with the 2009 North American Frost & Sullivan Award for Growth Strategy Leadership of the Year. The annual award is based on an analysis of the most significant drug-discovery innovations and acknow...

Genetic discovery could lead to advances in dental treatment

CORVALLIS, Ore. Researchers have identified the gene that ultimately controls the production of tooth enamel, a significant advance that could some day lead to the repair of damaged enamel, a new concept in cavity prevention, and restoration or even the production of replacement teeth. The gen...

Accidental discovery has potential for new applications in packaging

CLEVELAND A recent discovery at Case Western Reserve University may help keep food and drugs safer and fresher longer and electronic equipment dryer and more secure than ever before all at a lower cost. The finding involves a nanotechnology-based technique to block the transport of damaging g...

Novel Diabetes Drug Discovery Has Potential to Reverse Disease

WYNNEWOOD, Pa., Jan. 27 /PRNewswire/ -- A study released today in Endocrine Practice (2008;14:1075), the leading peer-reviewed journal for practicing endocrinologists in the US and 65 countries, reports a ground breaking discovery with the potential to reverse type 1 and 2 diabetes. Scientists ...

U of T chemistry discovery brings organic solar cells a step closer

Inexpensive solar cells, vastly improved medical imaging techniques and lighter and more flexible television screens are among the potential applications envisioned for organic electronics. Recent experiments conducted by Greg Scholes and Elisabetta Collini of University of Toronto's Departme...

Life Sciences Discovery Fund Awards $4.7 Million to Support New Vaccine Program

SEATTLE, Dec. 16 /PRNewswire/ -- The Washington Life Sciences Discovery Fund (LSDF) has awarded nearly $4.7 million to launch the start-up phase of the Washington Vaccine Alliance (WAVA) and to support initial research into three new vaccines for E. coli, herpes and syphilis. Announced today, the ...

Med Discovery and Laborium Biopharma Sign a Bioprocess Development Partnership Agreement

Med Discovery S.A., a Swiss biotech firm and Laborium Biopharma, a subsidiary of Validapro Biosciences Inc. have signed a partnership agreement for the development and optimization of protein bioprocess production and scale-up. Laval, Quebec (PRWEB) November 19, 2008 --...

Telik Announces New TRAP Drug Discovery Agreement

PALO ALTO, Calif., Nov. 12 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK ) announced today an agreement to provide its TRAP(R) drug discovery technology to investigators at the Hospital for Special Surgery (HSS). The Research Division of HSS studies the mechanisms underlying musculoskel...

TIBCO Speeds Drug Discovery for Chemists

TIBCO Spotfire Lead Discovery provides an easy-to-use, highly visual and interactive environment for exploring chemical structures and any associated data SOMERVILLE, Mass., Nov. 11 /PRNewswire-FirstCall/ -- TIBCO Software Inc. (Nasdaq: TIBX ), today announced the release of TIBCO Spotfire(...

Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts

Driven by the emergence of innovative technologies such as microfluidics, genomics, high throughput screening and proteomics, world market for drug discovery technologies is projected to reach $57.7 billion by 2012. Despite the heavy costs involved in discovery of new drugs, investments in pharma...

deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer

Latest discoveries add to understanding of individual risk of basal cell carcinoma, and are integrated into the deCODEme(TM) personal genome analysis scan REYKJAVIK, Iceland, Oct. 13 /PRNewswire-FirstCall/ -- Scientists at deCODE genetics (Nasdaq: DCGN ) today report the discovery of common...

Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline

U.S. National Institutes of Health, The Infectious Disease Research Institute and Eli Lilly and Company Announce Launch and Board of Advisors SEATTLE, Oct. 7 /PRNewswire-FirstCall/ -- The Lilly TB Drug Discovery Initiative today announced its first acquisition of compounds for further devel...

The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline

U.S. National Institutes of Health, The Infectious Disease Research Institute and Eli Lilly and Company Announce Launch and Board of Advisors SEATTLE, Oct. 7 /PRNewswire-FirstCall/ -- The Lilly TB Drug Discovery Initiative today announced its first acquisition of compounds for further devel...

Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration

OSLO, September 23 /PRNewswire/ -- Affitech AS, the Norwegian human antibody therapeutics company, today announced that it has accomplished the second milestone in its research and licensing collaboration with Roche to produce fully human recombinant antibodies against an unnamed oncology targ...

ChanTest to Highlight the World's Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Assays & Cellular Targets Conference, Booth 11

Company CEO is featured speaker: "Case Study - Screening Ion Channels for Safety and Efficacy" on Friday, September 26 at 11:30 CLEVELAND, Sept. 18 /PRNewswire/ -- ChanTest will feature its expanding line of ion channel services and cell lines for drug-discovery and development applicat...

Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA)

ANN ARBOR, Mich., Sept. 15 /PRNewswire/ -- Assay Designs and the Spinal Muscular Atrophy Foundation (SMAF) are very pleased to announce a collaborative agreement for development of reagents and assays for SMN (Survival Motor Neuron) protein to expedite drug discovery and development efforts fo...

Biotechnology & Drug Discovery Markets Push Up Demand for Lab Automation Products, According to a New Report by Global Industry Analysts

Growth in the laboratory automation industry is expected from increased demand for complex and higher throughput systems in biotechnology and pharmaceutical markets. The advent of advanced and sophisticated technologies with enhanced focus on rapid, accurate and timely results is contributing to ...

ChanTest to Highlight the World's Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Ion Channel Targets, Booth 5

Company CEO is featured speaker: 'Ion Channel Panels for Safety Assessment and Drug Discovery' on Tuesday, September 9th at 2:30 CLEVELAND, Sept. 8 /PRNewswire/ -- ChanTest, the preeminent provider of validated ion channel-expressing cell lines and services for drug-discovery and develo...

Concentric Named Professional Agency of Record for Discovery Labs' SURFAXIN(R)

NEW YORK, Sept. 3 /PRNewswire/ -- Concentric Pharma Advertising, one of the fastest growing marketing agencies in the healthcare field, has been named agency of record by Discovery Labs for SURFAXIN(R) (lucinactant), an investigational drug being reviewed by the Food and Drug Administration fo...

Affitech and Omeros Enter Into Antibody Discovery and Development Agreement

SEATTLE and OSLO, Norway, Aug. 19 /PRNewswire/ -- Omeros Corporation, a Seattle-based clinical-stage biopharmaceutical company, and Affitech AS, a Norwegian human antibody therapeutics company, today announced that they have entered into an agreement for the discovery and development of fully ...

IBC Life Sciences Kicks Off the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress in Boston, Massachusetts

Featuring Four Keynote Presentations, Four Pre-Conference Summits, Six Therapeutics Conference Topics, Three Post-Conference Workshops and Over One Hundred and Seventy Exhibitors WESTBOROUGH, Mass., Aug. 4 /PRNewswire/ -- Today IBC Life Sciences kicks off the 13th Annual D...

VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics World Congress

SAN FRANCISCO, Aug. 1 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that Rebecca A. Taub, MD, VIA's senior vice president of research and develop...

Insmed CEO to Present at Drug Discovery & Development Conference

CEO Geoffrey Allan Will Discuss Company's IPLEX(TM) Program in Myotonic Muscular Dystrophy RICHMOND, Va., July 25 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM) a developer of follow-on biologics and biopharmaceuticals, today announced that Geoffrey Allan, Ph.D....
Other Tags
(Date:7/30/2014)... the Entomological Society of America (ESA) has elected ten ... as a Fellow acknowledges outstanding contributions to entomology in ... or administration. The following Fellows will be recognized during ... will be held November 16-19, 2014 in Portland, Oregon. ... professor with the Department of Plant, Soil and Entomological ...
(Date:7/30/2014)... received a pledge of $1 million from the Cornelia ... new Neurobehavioral Biometry Center. , The newly ... the Laboratory to develop a greater breadth and depth ... of accelerating the pace of research to improve human ... premier resource for the Laboratory and its external partners, ...
(Date:7/30/2014)... shrinking ranges and a changing climate threaten some ... plants, and so conservationists establish seed collections to ... in hopes of preserving some genetic diversity., For ... simple models that offer a one-size-fits-all approach for ... saving 50 seed samples regardless of species, pollination ...
Breaking Biology News(10 mins):Entomological Society of America recognizes 2014 fellows 2Entomological Society of America recognizes 2014 fellows 3Entomological Society of America recognizes 2014 fellows 4Entomological Society of America recognizes 2014 fellows 5Entomological Society of America recognizes 2014 fellows 6Entomological Society of America recognizes 2014 fellows 7Entomological Society of America recognizes 2014 fellows 8Entomological Society of America recognizes 2014 fellows 9Entomological Society of America recognizes 2014 fellows 10Entomological Society of America recognizes 2014 fellows 11Entomological Society of America recognizes 2014 fellows 12Entomological Society of America recognizes 2014 fellows 13Entomological Society of America recognizes 2014 fellows 14Entomological Society of America recognizes 2014 fellows 15Entomological Society of America recognizes 2014 fellows 16Entomological Society of America recognizes 2014 fellows 17Rossi Foundation pledges $1M for JAX neurobehavioral research center 2Saving seeds the right way can save the world's plants 2
(Date:7/30/2014)... The Technology Association of Georgia in collaboration ... today issued its final call for applications and nominations ... have until August 29th 2014 to be considered for ... by the Excalibur Judging Committee. Companies selected as semi-finalists ... for interviewing process. , The TAG Excalibur Awards ...
(Date:7/30/2014)... 2014 The Ehlers-Danlos National Foundation (EDNF) ... Sandra Aiken Chack will serve as chair. The board ... 2014 Annual Learning Conference in Houston, Texas July 10-12. ... agenda ahead of us. From the rollout of the ... the Greater Baltimore Medical Center to our September physicians ...
(Date:7/30/2014)... CA (PRWEB) July 30, 2014 Over ... Chao Pinhole Surgical Technique®, the revolutionary minimally invasive treatment ... Shanelec, considered by many of his peers to be ... guest speaker at a recent Chao Pinhole Surgical Technique® ... CA. Dr. Shanelec is the recipient of the American ...
(Date:7/30/2014)... LTC Consumer, an independent, free online service to help ... Instant Quote tool on its website, LTCconsumer.com , announced ... are free and unlimited. , The Instant Quote tool ... including age, gender, and state of residence – and delivers ... to enter any contact information to get started). There is ...
(Date:7/30/2014)... As the controversy surrounding the use ... continues to grow, Bernstein Liebhard LLP notes that another ... a ban on uterine morcellation. According to a report ... leiomyosarcoma following a hysterectomy that involved the use of ... the aggressive cancer had progressed to Stage 4. Ms. ...
Breaking Medicine News(10 mins):Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 2Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 3Health News:Ehlers-Danlos National Foundation Announces New Leadership 2Health News:Periodontist Dr. Dennis Shanelec Comments On The Chao Pinhole Surgical Technique® Training Course 2Health News:LTC Consumer Launches Online Tool for Getting Instant Long Term Care Insurance Estimates 2Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 2Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 3Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 4
Other Contents